Synektik S.A. Logo

Synektik S.A.

Radiopharmaceuticals, medical devices & IT solutions for oncology, cardiology, and neurology.

SNT | WAR

Overview

Corporate Details

ISIN(s):
PLSNKTK00019
LEI:
259400U0O19JWLVHQN14
Country:
Poland
Address:
WARSZAWA JÓZEFA PIUSA DZIEKOŃSKIEGO 3, 00-728 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Synektik S.A. is a leading manufacturer and supplier of advanced radiopharmaceutical products used in medical diagnostics and therapy, particularly for Positron Emission Tomography (PET/CT). The company also distributes innovative medical equipment and develops proprietary IT solutions, including specialized software for medical data archiving and analysis. Additionally, Synektik provides comprehensive maintenance, service, and measurement testing for medical devices. The group integrates these solutions to support advancements in oncology, cardiology, and neurology.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Synektik S.A. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-16 16:47
Related Party Transaction
Uzupełnienie informacji o zawarciu istotnej umowy sprzedaży systemu robotyczneg…
Polish 1.3 KB
2025-09-16 15:04
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.8 KB
2025-09-16 13:26
Related Party Transaction
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.5 KB
2025-09-12 09:23
Related Party Transaction
Informacja o zawarciu istotnej umowy dot. udzielenia licencji na produkcję Glun…
Polish 1.8 KB
2025-09-10 10:57
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-09-03 09:15
Audit Report / Information
Opinia Biegłego
Polish 344.4 KB
2025-09-03 09:15
M&A Activity
Plan Podziału
Polish 1.6 MB
2025-09-03 09:15
Legal Proceedings Report
Opinia biegłego rewidenta z badania Planu Podziału - Content (PL)
Polish 1.8 KB
2025-08-12 12:00
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży - Content (PL)
Polish 2.1 KB
2025-08-11 08:29
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-08-08 15:37
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-08-07 07:49
Interim Report
Śródroczne skrócone skonsolidowane sprawozdanie finansowe za 3 kw. 2024
Polish 1.3 MB
2025-08-07 07:49
Quarterly Report
wybarane dane finansowe za 3 kw. 2024
Polish 200.8 KB
2025-08-05 15:10
Legal Proceedings Report
Informacja o zawarciu istotnej umowy sprzedaży - Content (PL)
Polish 1.3 KB
2025-07-29 15:11
Legal Proceedings Report
Informacja o zawarciu istotnej umowy sprzedaży - Content (PL)
Polish 1.4 KB

Automate Your Workflow. Get a real-time feed of all Synektik S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Synektik S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK

Talk to a Data Expert

Have a question? We'll get back to you promptly.